Leica Microsystems, Inc. recalls PROVEO 8 Ophthalmic Microscope System optical instrument for improving the visibility of objects through magnification…
- Recall date
- September 25, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0838-2019
- FDA classification
- Class II
- Brand / firm
- Leica Microsystems, Inc.
- Sold / distributed
- Worldwide
Why it was recalled
The observed issues can lead to unexpected interruptions of the optics carrier focus drive movement, intermittent stops of the X-Y coupling movement or sporadic failures in the proper on-screen display functionality of the HDR recording unit. Additionally, an anomaly in the device software may also lead to the unexpected behavior that when a user releases a handle or foot switch button this may not immediately end the actuated functionality. This behavior can only occur in unlikely workflows where a user changes a user profile or a mode change is initiated at the same time as a functional button is activated.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PROVEO 8 Ophthalmic Microscope System optical instrument for improving the visibility of objects through magnification and illumination. It can be applied for observation and documentation and for human and veterinary medical treatment.
Get recall alerts
Free email alert whenever Leica Microsystems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Leica Microsystems, Inc.